The risk factors and clinical outcomes of upper extremity deep vein thrombosis

Vascular and Endovascular Surgery

Volumn 46, Issue 2, 2012, Pages 139-144

  Lee, Jung Ah ^a   Zierler, Brenda K ^b,c   Zierler, R Eugene ^c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

mortality; outcomes; prophylaxis; pulmonary embolism; risk factors; upper extremity deep vein thrombosis; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARM SWELLING; CANCER PATIENT; CENTRAL VENOUS CATHETER; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INDWELLING CATHETER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT;

ACADEMIC MEDICAL CENTERS; ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UPPER EXTREMITY DEEP VEIN THROMBOSIS; WASHINGTON; YOUNG ADULT;

EID: 84863360315     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574411432145     Document Type: Review

References (32)

1. Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997 ; 26 (5). 853-860 (Pubitemid 27505624)
2. Prandoni P, Bernardi E.. Upper extremity deep vein thrombosis. Curr Opin Pulm Med. 1999 ; 5 (4). 222-226
3. Kucher N.. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med. 2011 ; 364 (9). 861-869
4. Baarslag HJ, Koopman MM, Reekers JA, van Beek EJ.. Diagnosis and management of deep vein thrombosis of the upper extremity: a review. Eur Radiol. 2004 ; 14 (7). 1263-1274 (Pubitemid 38979221)
5. Hill SL, Berry RE.. Subclavian vein thrombosis: a continuing challenge. Surgery. 1990 ; 108 (1). 1-9 (Pubitemid 20220162)
6. Kommareddy A, Zaroukian MH, Hassouna HI.. Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2002 ; 28 (1). 89-99 (Pubitemid 34194876)
7. Grove JR, Pevec WC.. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000 ; 11 (7). 837-840 (Pubitemid 30485094)
8. Allen AW, Megargell JL, Brown DB, et al. Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol. 2000 ; 11 (10). 1309-1314
9. Luciani A, Clement O, Halimi P, et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology. 2001 ; 220 (3). 655-660 (Pubitemid 32799971)
10. Karabay O, Yetkin U, Onol H.. Upper extremity deep vein thrombosis: clinical and treatment characteristics. J Int Med Res. 2004 ; 32 (4). 429-435 (Pubitemid 39069515)
11. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ.. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004 ; 110 (12). 1605-1611 (Pubitemid 39297983)
12. Schmittling ZC, McLafferty RB, Bohannon WT, Ramsey DE, Hodgson KJ.. Characterization and probability of upper extremity deep venous thrombosis. Ann Vasc Surg. 2004 ; 18 (5). 552-557 (Pubitemid 39223539)
13. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation. 2004 ; 110 (5). 566-570 (Pubitemid 39031174)
14. Tham J, Albertsson M.. Upper extremity deep venous thrombosis in patients with 5-fluorouracil-containing adjuvant chemotherapy-three case reports and a review. Acta Oncol. 2004 ; 43 (1). 108-112 (Pubitemid 38283181)
15. Shah MK, Burke DT, Shah SH.. Upper-extremity deep vein thrombosis. South Med J. 2003 ; 96 (7). 669-672
16. Gonsalves CF, Eschelman DJ, Sullivan KL, DuBois N, Bonn J.. Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement. Cardiovasc Intervent Radiol. 2003 ; 26 (2). 123-127 (Pubitemid 36919551)
17. Chemaly RF, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002 ; 34 (9). 1179-1183 (Pubitemid 34450664)
18. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010 ; 138 (4). 803-810
19. De Cicco M.. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004 ; 50 (3). 187-196 (Pubitemid 38746533)
20. Hingorani A, Ascher E, Markevich N, et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg. 2005 ; 41 (3). 476-478 (Pubitemid 40523592)
21. Ascher E, Salles-Cunha S, Hingorani A.. Morbidity and mortality associated with internal jugular vein thromboses. Vasc Endovascular Surg. 2005 ; 39 (4). 335-339 (Pubitemid 41061700)
22. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS.. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost. 2005 ; 93 (3). 499-502 (Pubitemid 40392539)
23. Baarslag HJ, Koopman MM, Hutten BA, et al. Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome. Eur J Intern Med. 2004 ; 15 (8). 503-507 (Pubitemid 40164479)
24. Hingorani A, Ascher E, Ward M, et al. Combined upper and lower extremity deep venous thrombosis. Cardiovasc Surg. 2001 ; 9 (5). 472-477 (Pubitemid 32728010)
25. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001 ; 119 (1 suppl). 132S - 175S (Pubitemid 32162075)
26. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 ; 126 (3 suppl). 338S - 400S (Pubitemid 39302602)
27. Masci G, Magagnoli M, Zucali PA, et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?. J Clin Oncol. 2003 ; 21 (4). 736-739 (Pubitemid 46621911)
28. Magagnoli M, Masci G, Carnaghi C, et al. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen. Ann Oncol. 2003 ; 14 (6). 959-960 (Pubitemid 36827213)
29. Verso M, Agnelli G, Bertoglio S, et al. Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: a Double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol. 2005 ; 23 (18). 4057-4062 (Pubitemid 46211310)
30. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest. 2008 ; 133 (6 suppl). 381S - 453S (Pubitemid 351894916)
31. McGarry LJ, Thompson D.. Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice. Clin Ther. 2004 ; 26 (3). 419-430 (Pubitemid 38457335)
32. Merli GJ.. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment. J Thromb Thrombolysis. 2004 ; 18 (2). 117-125 (Pubitemid 40485117)